{
  "id": "5a8dc57ffcd1d6a10c000025",
  "type": "yesno",
  "question": "Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?",
  "ideal_answer": "The human bombesin receptors, GRPR and NMBR, are two of the most frequently overexpressed G-protein-coupled-receptors by lung-cancers",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25554218",
    "http://www.ncbi.nlm.nih.gov/pubmed/18975117",
    "http://www.ncbi.nlm.nih.gov/pubmed/20438784",
    "http://www.ncbi.nlm.nih.gov/pubmed/10545285",
    "http://www.ncbi.nlm.nih.gov/pubmed/21060250",
    "http://www.ncbi.nlm.nih.gov/pubmed/22828605"
  ],
  "snippets": [
    {
      "text": "Members of the gastrin-releasing peptide (GRP) family and its analogs bombesin (BBN) have been implicated in the biology of several human cancers including prostate, breast, colon and lung.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18975117",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "All 3 bombesin receptor subtypes (GRPR, NMBR, and BRS-3) were present on pulmonary and intestinal carcinoids by immunohistochemistry",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21060250",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There is increased interest in the Bn-receptor family because they are frequently over/ectopically expressed by tumors and thus useful as targets for imaging or receptor-targeted-cytotoxicity. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22828605",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25554218",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Gastrin-releasing peptide (GRP), a member of the bombesin family of peptides, has been shown to have mitogenic activity in small cell lung carcinoma (SCLC), and to be produced by SCLC in an autocrine fashion.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10545285",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D018004",
    "https://meshb.nlm.nih.gov/record/ui?ui=D008175"
  ],
  "exact_answer": "Yes"
}